Development of a highly effective combination monoclonal antibody therapy against Herpes simplex virus

Infections with Herpes simplex virus (HSV)-1 or -2 usually present as mild chronic recurrent disease, however in rare cases can result in life-threatening conditions with a large spectrum of pathology. Monoclonal antibody therapy has great potential especially to treat infections with virus resistan...

Descrizione completa

Dettagli Bibliografici

Autori principali:	Seyfizadeh, Narges (Autore) , Kalbermatter, David (Autore) , Imhof, Thomas (Autore) , Ries, Moritz (Autore) , Müller, Christian (Autore) , Jenner, Leonie (Autore) , Blumenschein, Elisabeth (Autore) , Yendrzheyevskiy, Alexandra (Autore) , Grün, Frank (Autore) , Moog, Kevin (Autore) , Eckert, Daniel (Autore) , Engel, Ronja (Autore) , Diebolder, Philipp (Autore) , Chami, Mohamed (Autore) , Krauß, Jürgen (Autore) , Schaller, Torsten (Autore) , Arndt, Michaela (Autore)
Natura:	Article (Journal)
Lingua:	inglese
Pubblicazione:	2024
In:	Journal of biomedical science Year: 2024, Volume: 31, Pages: 1-22$p22
ISSN:	1423-0127
DOI:	10.1186/s12929-024-01045-2
Accesso online:	Verlag, kostenfrei, Volltext: https://doi.org/10.1186/s12929-024-01045-2 Verlag, lizenzpflichtig, Volltext: https://jbiomedsci.biomedcentral.com/articles/10.1186/s12929-024-01045-2
Note sull'autore:	Narges Seyfizadeh, David Kalbermatter, Thomas Imhof, Moritz Ries, Christian Müller, Leonie Jenner, Elisabeth Blumenschein, Alexandra Yendrzheyevskiy, Frank Grün, Kevin Moog, Daniel Eckert, Ronja Engel, Philipp Diebolder, Mohamed Chami, Jürgen Krauss, Torsten Schaller and Michaela Arndt